Related Experiment Video
Updated: Sep 20, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Coronary artery bypass surgery in patients with severe left ventricular dysfunction
C Selim Isbir1, Tekin Yildirim, Serdar Akgun
1Department of Cardiovascular Surgery, Marmara University School of Medicine, Istanbul, Turkey.
Insights
Coronary artery bypass grafting (CABG) is feasible in patients with severe left ventricular dysfunction, offering acceptable mortality and encouraging mid-term survival. Preoperative intra-aortic balloon pump (IABP) support significantly improves outcomes.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery
- Interventional Cardiology
Background:
- Severe left ventricular dysfunction presents significant challenges for cardiac surgery.
- Coronary artery bypass grafting (CABG) is a potential treatment option for these high-risk patients.
Purpose of the Study:
- To evaluate the role and outcomes of CABG in patients with ejection fraction (EF) below 30%.
- To identify factors influencing survival in this patient cohort.
Main Methods:
- A retrospective analysis of 212 patients with EF < 30% who underwent CABG.
- Data collected on preoperative conditions, surgical techniques (including left internal mammary artery (LIMA) use and endarterectomy), and postoperative outcomes.
- Follow-up for up to 58 months.
Main Results:
- In-hospital mortality was 5.6%.
- 1, 2, 3, and 4-year survival rates were 94%, 87%, 80%, and 73%, respectively.
- Preoperative intra-aortic balloon pump (IABP) support significantly improved operative mortality (P=0.002), while LIMA use did not impact survival.
Conclusions:
- CABG can be performed with acceptable mortality in patients with poor left ventricular function.
- Mid-term survival results following CABG for severe left ventricular dysfunction are encouraging.
- Preoperative IABP support is a critical factor in improving survival rates for these patients.
Objective:
The role of coronary artery bypass grafting (CABG) in patients with severe left ventricular dysfunction was evaluated.
Methods:
Two hundred and twelve patients (152 men, 60 women; age 35 to 82, mean 55) with ejection fraction (EF) of less than 30% underwent CABG between January 1996 and February 2001 by a single surgeon (SA). They compromised of 12% of 1759 patients operated on in this period. EF ranged from 17% to 30% (mean 25%). Preoperatively 68% had congestive heart failure and 72% had severe angina (CCS 3 or 4). A left main lesion was found in 26% of the cases. The mean number of grafts was 3.18 per patient. The left internal mammary artery (LIMA) was used on 107 patients (50.4%). Preoperative intraaortic balloon pump (IABP) was used on 32 patients (15%). Endarterectomy was performed on 53 patients (25%). The patients were followed for up to 58 months (mean 28.7).
Results:
Twelve patients died in hospital (5.6%). Survival was 94%, 87%, 80% and 73% at 1, 2, 3 and 4 years respectively. Among the preoperative variables survival was negatively affected by chronic renal failure, older age, congestive heart failure, elevated pulmonary artery pressure and recent myocardial infarction, by means of multivariate analysis. Preoperative IABP support improved the operative mortality significantly (P=0.002). Use of LIMA did not have any influence on survival.
Conclusion:
CABG on patients with poor left ventricular function: (1). Can be performed with an acceptable mortality. (2). Mid term results are encouraging. (3). Preoperative IABP support improves the chance of survival.
More Related Videos
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)
Published on: April 24, 2017
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure VI: Adjunct Therapies